Cryptochromes are evolutionarily related to the light-dependent DNA repair enzyme photolyase, serving as major regulators of circadian rhythms in insects and vertebrate animals. There are two types of cryptochromes in the animal kingdom: Drosophila-like CRYs that act as nonvisual photopigments linking circadian rhythms to the environmental light/ dark cycle, and vertebrate-like CRYs that do not appear to sense light directly, but control the generation of circadian rhythms by acting as transcriptional repressors. Some animals have both types of CRYs, while others possess only one. Cryptochromes have two domains, the photolyase homology region (PHR) and an extended, intrinsically disordered C-terminus. While all animal CRYs share a high degree of sequence and structural homology in their PHR domains, the C-termini are divergent in both length and sequence identity. Recently, cryptochrome function has been shown to extend beyond its pivotal role in circadian clocks, participating in regulation of the DNA damage response, cancer progression and glucocorticoid signaling, as well as being implicated as possible magnetoreceptors. In this review, we provide a historical perspective on the discovery of animal cryptochromes, examine similarities and differences of the two types of animal cryptochromes and explore some of the divergent roles for this class of proteins.
INTRODUCTION
Earth receives almost all of its energy from the Sun's radiation, which provides the driving force for the photosynthetic production of oxygen, patterns of climate and weather and the coordination of our behavior and physiology with its daily light/dark cycle. Sunlight also contains harmful ultraviolet (UV) radiation that can induce mutations in DNA to interfere with genetic stability. One of the most elegant solutions for the repair of UV-induced DNA damage occurs by a process termed photoreactivation, in which UV-induced pyrimidine dimers are repaired enzymatically with blue light (1) . Photolyase enzymes specifically recognize cyclobutane pyrimidine dimers or pyrimidine-pyrimidone (6-4) photoproducts, both of which accumulate when DNA is exposed to sunlight (2, 3) . After recognition of damaged DNA, photolyase captures a photon of blue light with one of its two light-harvesting cofactors, a secondary antenna chromophore (either methenyltetrahydrofolate (MTHF) or the deazaflavin, 8-HDF) or the catalytic chromophore flavin adenine dinucleotide (FAD), which undergoes an electron transfer cycle to split the pyrimidine dimer (4) .
Not all organisms possess the capability to photoreactivate; those that do not have photolyase use mechanisms such as nucleotide excision repair to replace damaged DNA (5) . Photolyase homologs that lack DNA repair activity, known as cryptochromes, were first discovered over 20 years ago in plants, followed by insects, vertebrates, and are now found across the domains of life (6) . By definition, cryptochromes lack DNA repair activity, but they capitalize on their evolutionary relationship to photolyase to regulate other aspects of our intimate biological relationship with the Sun. Although insect and vertebrate-like cryptochromes have different functions, both remain primarily associated with biological clocks that serve as an interface between host physiology, behavior and the daily light/dark cycle. However, new roles are being revealed for animal cryptochromes outside circadian clocks, including their involvement in cancer biology and the response to DNA damage, metabolic signaling and possibly even in magnetoreception. Here, we provide a historical perspective on our understanding of cryptochromes and how our knowledge of photolyase structure and function has informed studies on cryptochrome.
Biological timekeeping by circadian rhythms
Circadian rhythms are nearly 24-h rhythms of physiology and behavior that are a nearly ubiquitous feature of eukaryotic life. These internal rhythms were first noted by Jean-Jacques de Marain (1678-1771), who observed that the daily opening and closing of the flowers of a Mimosa plant persisted in total darkness. The modern field of circadian rhythms was established by J€ urgen Aschoff (1913 Aschoff ( -1998 and Colin Pittendrigh (1918 , who delineated the defining properties of these rhythms: Circadian rhythms are self-sustaining in the absence of external time cues and possess an intrinsic (or free-running) period of approximately 24 h under constant conditions such as complete darkness. Circadian rhythms are synchronized (or entrained) to the 24-h solar light/dark cycle and exhibit relatively constant free-running periods with changes in temperature (7) .
Under 24-h light/dark cycles (i.e. 12-h light and 12-h dark, or LD 12:12), circadian rhythms demonstrate a period of exactly 24 h. However, in constant conditions that occur in the absence of environmental cues, these rhythms display their internal free-running periods, which are close to, but usually not exactly, 24 h. For instance, the human sleep-wake cycle has a free-running period of about 24.3 h, while the mouse has a rest-activity rhythm with a free-running period of about 23.6 h (8). Light acts as a time cue (or Zeitgeber) to entrain internal rhythms to the exact 24-h solar day. Light accomplishes this by shifting the phase of free-running rhythms to match the environmental light/dark cycle. Most organisms share a common phase response to light, whereby a short pulse of light during the subjective day (i.e. a time that coincides with daytime based on the free-running clock of an organism in complete darkness) does not shift the clock, but a pulse of light in the early subjective night phase delays the clock, while the same pulse of light given in the late subjective night phase advances the clock. By virtue of being able to shift the phase of internal rhythms with brief pulses of light, circadian clocks provide organisms with the ability to align physiology and behavior to daily environmental cycles for enhanced fitness (9). Remarkably, the spectral character of light that phase-shifts the clock is also relatively conserved across a broad range of phylogeny and is centered in the blue portion of the spectrum.
Circadian rhythms in Drosophila. Colin Pittendrigh was the first to study the circadian rhythms of Drosophila (7). He noted that flies show two separate free-running rhythms, one of eclosion from pupae to adult and a second in locomotion. Both are entrainable by light. Using Drosophila genetics, Ron Konopka (1947 Konopka ( -2015 and Seymour Benzer (1921-2007) performed mutagenesis on flies and identified three mutants with abnormal freerunning rhythms (one with a long period, one with a short period and an arrhythmic mutant) (10) . Remarkably, all three mapped to a single gene, dubbed period due to its profound effects on the timing, or period, of circadian rhythms (11, 12) . Equally remarkably, period mutants affected both eclosion rhythms and locomotor rhythms in the same way. Work over several decades since has demonstrated that the circadian clock mechanism in Drosophila consists of a small number of dedicated clock genes (i.e. period, timeless, clock, cycle) that establish a time-delayed transcription-translation feedback loop controlling circadian expression of a number of genes (13) .
Cryptochromes as circadian photoreceptors
The search for a circadian photoreceptor. Drosophila circadian rhythms are entrainable to light/dark cycles. It would be logical to assume that the eyes and visual system mediate this effect. However, studies with eyeless mutants such as norpA and glass demonstrated that blind flies maintained behavioral entrainment to light/dark cycles (14) . Further, severe vitamin A depletion that rendered visual opsins nonfunctional did not block light-induced phase shifting (15) . In addition, explanted tissues from Drosophila expressing green fluorescent protein under the control of the period promoter/enhancer elements showed direct photoentrainment in culture (16) despite the absence of opsin expression in these tissues. Collectively, these lines of evidence suggested the presence of a cell-autonomous circadian photoreceptor.
In 1998, Stanewsky et al. (17) conducted a forward mutagenesis screen in Drosophila designed to identify additional clock genes. Using a luciferase reporter driven by the period gene, this group found a recessive mutation that blunted circadian gene oscillations. The mutation mapped to the Drosophila cryptochrome (cry) locus and was named cry b (short for "crybaby"). Previously, light was shown to reduce expression of the TIMELESS (TIM) protein, one of the core clock genes in Drosophila; cry b -mutant flies no longer exhibited the light-dependent reduction in TIM protein levels. Based on its similarity to photolyase and plant cryptochromes that act as blue light photoreceptors, cry was suspected of encoding a circadian receptor in flies. In addition, cry b flies did not phase-shift their rhythms to short, bright pulses of light and overexpression of CRY protein resulted in flies that were supersensitive to phase shifting by light. Of note, cry b flies still demonstrated free-running behavioral rhythms and showed some behavioral entrainment to light. However, this entrainment was lost when cry b -mutant flies were compounded with the glass mutation (18) , which removes all known photoreceptors in the fly eye. Taken together, these results strongly suggested that Drosophila CRY functions as the primary blue light photopigment that mediates circadian photoentrainment.
To test this, Emery and colleagues established an in vitro system to study cryptochrome's photoreceptive function (19) . In cultured Drosophila S2 cells expressing CRY and TIM, exposure to light resulted in the rapid degradation of TIM, followed by the substantially slower degradation of CRY itself. These results suggested that light might induce a structural change in CRY that allows it to interact with TIM, similar to light-dependent changes in conformation observed with Arabidopsis cryptochromes (20, 21) . The discovery of two novel alleles of cryptochrome (cry m and cryD) missing the short, C-terminal extension from the photolyase homology region (PHR) supported this model (19, 22) . Wild-type CRY bound TIM only after exposure to light (23, 24) , while deletion of the CRY C-terminal extension led to constitutive interactions with TIM that triggered its degradation (19, 25) . The E3 ubiquitin ligase encoded by Jetlag was subsequently found to be the protein that recognized TIM after interaction with CRY, marking it for degradation to induce phase shifts in the circadian clock (Fig. 1a) (26) (27) (28) .
Following on these in vitro studies, Chavez et al. (29) developed a cryptochrome-luciferase (CRY-luc) fusion protein to characterize light-mediated CRY degradation in S2 cells. They found that a one-hour exposure to light resulted in >80% degradation of the CRY-luc fusion protein. Using this assay, Chavez et al. measured the action spectrum for CRY degradation, demonstrating that maximum degradation of CRY occurred when S2 cells were supplied with near UV light at approximately 380 nm. Lightdependent CRY degradation was blocked by the proteasomal inhibitor MG132, strongly suggesting that CRY, like TIM, is degraded by the proteasome after ubiquitination. However, JETLAG does not regulate CRY degradation in response to light (30) .
In subsequent work, Ozturk et al. (30) knocked down every known F-box E3 ubiquitin ligase present in S2 cells to identify the proteins that recognize light-activated cryptochrome in the fly. One E3 ligase, BRWD3 encoded by the ramshackle gene, resulted in loss of light-dependent CRY degradation in S2 cells.
CRY and BRWD3 were shown to interact in a light-dependent manner by a yeast two-hybrid assay, and purified CRY and BRWD3 proteins formed complex only after exposure to light to result in the ubiquitination of CRY in vitro. Therefore, Drosophila CRY undergoes a light-dependent change in conformation that regulates its ability to interact with TIM and BRWD3, controlling the stability of both TIM and CRY itself.
Photochemistry and phototransduction of Drosophila CRY. The photocycle of Drosophila cryptochrome was initially assumed to be similar to that of Arabidopsis cryptochromes (31) (32) (33) . Like their ancestral photolyase homolog, cryptochromes can bind noncovalently to a flavin adenine dinucleotide (FAD) chromophore to absorb blue light. When Drosophila CRY protein was first purified from S2 cells, the catalytic chromophore FAD was found in an oxidized state (FAD OX ) that has been generally assumed to represent the ground state of cryptochromes. cence and paramagnetic spin techniques that both Drosophila and human cryptochromes could be photoreduced by light in Sf21 cell culture. Structurally, this electron transfer appears to be dependent on a triad of conserved tryptophan residues (Trp-342, -397 and -420) (37) (38) (39) . However, mutagenesis of the "Trp triad" as well as a fourth tryptophan (Trp-536) did not affect light-induced proteolysis of CRY or TIM in S2 cells (34, 40) . Crane and colleagues then showed that chemical reduction of the dCRY flavin is sufficient to trigger conformational changes in the protein that are similar to those induced by light (41) . Therefore, reduction of the flavin by either light excitation or chemical reduction thus appears to be sufficient to cause conformational changes that are important for CRY activation.
Similar to those observed with Arabidopsis CRYs, lightdependent changes in the structure of Drosophila CRY are easily assayed by limited trypsin proteolysis in vitro (20, 27) . It was shown that absorption of light efficiently drove changes in both oxidized and reduced CRY in vitro. The structural basis for conformational changes driven by light excitation or chemical reduction of the flavin in Drosophila CRY is predicted by crystal structures of its dark-adapted state, which depict how a hydrophobic motif ("FFW") in the C-terminal extension docks onto the PHR domain in close proximity to the flavin (Fig. 1b) (37, 38) . While some of the mechanistic details of CRY signaling still remain to be determined (42) , it appears that light-induced changes in Drosophila CRY structure are relatively long-lasting -on the order of 30 min-after even a millisecond pulse of light (43) . Further studies on the photocycle of Drosophila CRY and its mechanisms of phototransduction will help inform studies of its biological role in circadian entrainment.
Drosophila CRY as a magnetoreceptor. Remarkably, in addition to light sensing, it appears that cryptochromes may also mediate magnetoreception in Drosophila. In a binary-choice behavioral assay for magnetosensitivity, wild-type flies showed significant na€ ıve and trained responses to a magnetic field under full-spectrum light, but could not respond to a magnetic field when short wavelengths were blocked (44) . Moreover, cry b flies did not exhibit responses to a magnetic field under full-spectrum light, nor did the cryD mutant lacking the C-terminal extension (22) . Theoretical studies have suggested models explaining how light absorption could induce a paramagnetic triplet excited state in cryptochromes that allows for light-dependent magnetoreception, but it remains to be demonstrated that this is essential for magnetoreception (45) . Moreover, CRY was also recently shown to interact with Drosophila CG8198 (named MagR for magnetic receptor) to yield a protein complex that exhibits light-dependent responses to an induced magnetic field in vitro (46) . Genetic studies substituting Drosophila CRY with cryptochromes from vertebrates suggest that the capability to sense both light and magnetic field may be conserved in animals, while others have provided evidence of light-dependent conformational changes in some vertebrate cryptochromes that are expressed in the retina (43, 47, 48) .
Circadian photoreception in vertebrates. In the late 1990s, two cryptochrome homologs (Cry1 and Cry2) were identified in mice (49, 50) . Remarkably, Miyamoto and Sancar first suggested a role for cryptochromes in murine circadian rhythmicity in 1998 (51), before roles had been established for Drosophila and Arabidopsis cryptochromes, a rare case of gene function identified first in the mammal and subsequently shown to be critical in invertebrates or plants. Initially, a role for mammalian CRYs in circadian photoreception was suggested by photoentrainment experiments that mirrored early work conducted in flies. Mice blind from degeneration of the outer retina due to the rd1 mutation continued to show circadian entrainment to light, even to light as dim as 1-2 lux (52,53). Unlike the fly, which utilizes a cell-autonomous mechanism for circadian entrainment, mice that lacked eyes (through enucleation) or optic nerves did not exhibit circadian photoentrainment, demonstrating that mammals require retinal phototransduction to entrain to a light/dark cycle (54) . Cryptochromes seemed to be viable candidates for nonvisual phototransduction based on their expression in retinal ganglion cells (51) and similarity to Drosophila and Arabidopsis cryptochromes. Upon genetic deletion of both mouse cryptochromes, several lines of evidence suggested that the function of vertebrate cryptochromes might be quite different from Drosophila cryptochrome. While flies lacking cryptochrome continued to show behavioral rhythmicity, Cry1
-/-;Cry2 -/-mice no longer consolidated behavioral rhythms into circadian patterns (55, 56) . Subsequent work demonstrated that mammalian cryptochromes had taken over a role similar to TIM in the fly clock as the major binding partner of PER in the negative transcriptional complex of the core clock mechanism (57, 58) . Although the finding that cryptochromes function as essential transcriptional regulators in the mammalian clock mechanism complicated studies of entrainment, it did not formally eliminate the possibility that they might also function as circadian photopigments. Several lines of evidence initially supported this possibility. First, mice with severe vitamin A depletion (due to dietary vitamin A starvation in a retinol-binding protein-knockout background) continued to show light-dependent activation of gene expression in the suprachiasmatic nucleus of the hypothalamus, the site of the light-responsive "master clock" in mammals (59, 60) . Second, while Cry1
show masking-type effects in a light/dark cycle, the Cry1 -/-; Cry2 -/-;rd1/rd1 triple mutant resulted in substantially reduced rhythmicity and reduced c-fos activation in the suprachiasmatic nucleus in response to light (61) .
Melanopsin as a circadian photoreceptor. The discovery of mammalian melanopsin, a rhabdomeric opsin photopigment expressed in a small number of retinal ganglion cells, in 2000 soon led to its rise as the most likely candidate for a dedicated mammalian circadian photoreceptor (62) . Although originally discovered in the photosensitive dermal melanocytes of Xenopus (63), melanopsin was soon found to form a network of intrinsically photosensitive retinal ganglion cells in mice (64) (65) (66) (67) . While knockouts of melanopsin (Opn4) by itself had little effect on circadian entrainment, combining the rd1/rd1 mutation with deletion of melanopsin had a stronger phenotype than seen in mice with the rd1 mutation that also lacked both cryptochromes. Specifically, rd1/rd1;Opn4 -/ -animals had free-running rhythms that never entrained to external light/dark cycles, and had no pupillary light responses under any light intensities (68), while rd1/rd1;Cry1
mutants showed pupillary light responses, albeit with markedly decreased sensitivity (69) .
It appears that a combination of the unique signaling properties of melanopsin and effects due to the loss of circadian rhythms leads to the misattribution of cryptochrome as a circadian photopigment in mammals. Vitamin A depletion renders mice visually blind, as the ciliary opsins (rod and cone opsins) release their chromophore with each photocycle and are thus highly dependent on new, vitamin A-derived photopigment for restoring function. Melanopsin, by contrast, is a rhabdomeric opsin that appears to bind its chromophore irreversibly, using a combination of second photon absorption and thermal relaxation to regenerate its chromophore (70) . Subsequent work has shown that melanopsin is remarkably resistant to photic bleaching and can function in the absence of retinal pigment epithelium and other enzymes of the visual photocycle (62, 71 Thus, it appears that the role of cryptochromes is significantly different between insects and vertebrates. Whereas CRY is primarily a blue light photoreceptor that entrains circadian rhythmicity in Drosophila and other insects, cryptochromes in mammals and other vertebrates have evolved to become lightindependent transcriptional regulators within the core clock mechanism. Such results, however, must be reconciled with the finding that some vertebrate cryptochromes can bind flavin when purified from eukaryotic expression systems (36, 73, 74) and appear capable of substituting for Drosophila CRY in magnetoreception assays in vivo (75). However, if vertebrate cryptochromes retain the ability to signal in response to light, the physiology behind these influences remains to be discovered.
Commonalities and differences in animal cryptochromes
Evolutionary diversity of animal cryptochromes. Phylogenetic analysis of the photolyase/cryptochrome superfamily distributes the group into seven broad subfamilies: cyclobutane pyrimidine dimer (CPD) photolyase classes I-III, (6-4) photolyase, plant cryptochromes, animal cryptochromes and CRY-DASH, which selectively repairs UV-induced damage in single-stranded DNA and RNA (6, (76) (77) (78) . Animal cryptochromes are more similar to (6-4) photolyase than photolyases that repair cyclobutane pyrimidine dimers. The animal cryptochrome subfamily can be further divided into two groups: Type I cryptochromes, which are light-responsive circadian photoreceptors found only in Drosophila and other insects, and Type II cryptochromes in vertebrates (and some insects) that act as transcriptional repressors. Notably, one feature that appears to distinguish the molecular architecture of Drosophila and vertebrate clocks is the functional role of cryptochromes-does CRY act as a nonvisual photopigment for entrainment (Drosophila) or does it act as a transcriptional repressor (vertebrates)? However, even this distinction may not be clear-cut, as some studies show that Drosophila CRY may act as a transcriptional repressor in some tissues (13) . Furthermore, some species of insects have both types of animal cryptochromes (monarch butterflies and mosquitos), while others have only a vertebrate-like Type II cryptochrome (honeybees and ants) (79) (80) (81) . In yet another interesting twist, some vertebrates (chickens and zebrafish) possess yet another type of cryptochrome (Type IV) that is also sensitive to light, although functional roles for these cryptochromes have yet to be firmly established (6, 43, 48) .
Cryptochromes share a high degree of structural homology within their PHR domain both to each other and to all photolyases (37, 39, 82) . Despite this overarching similarity, variation in the PHR domains of animal cryptochromes may play a role in their profoundly different functions. Ning Zheng and colleagues first showed that mouse CRY2, a representative vertebrate cryptochrome, appears to have decreased affinity for FAD due to the presence of a much shallower FAD-binding pocket, further supporting their light-insensitive roles as transcriptional repressors (74) . Although the pockets in vertebrate CRYs may not be dedicated to chromophore binding, the conservation of these pockets might point to new roles for repressor-type CRYs.
There is also some indication that variation in the sequence composition and length of Type I and Type II cryptochromes may help to explain their diverse functions (Fig. 2a) . For example, mouse CRY1 and Drosophila CRY are only 43% identical, whereas honeybee CRY2 and mouse CRY1, both Type II cryptochromes, are 69% identical. A great deal of the sequence variation in animal cryptochromes falls outside of the PHR domain in their extended and intrinsically unstructured C-termini (Fig. 2b) . While the role of the Drosophila CRY C-terminus in regulating light-dependent interactions with target proteins is well established (19, 24, 25) , the role of C-termini in vertebrate-like cryptochrome function is less resolved. Studies of light-dependent Type IV cryptochromes suggest that their C-termini act similarly to Drosophila cryptochromes, exhibiting changes in conformation and/or interaction with the PHR domain in response to light (48) . The C-termini of Type II CRYs are not essential for circadian transcriptional repression, but their deletion led to changes in circadian period and the amplitude of cycling in genetic reconstitution assays (83) (84) (85) . Several groups have shown that phosphorylation of the C-termini of CRY1 and CRY2 regulates their stability, suggesting one mechanism by which the C-termini could affect circadian rhythms (86, 87) . The C-terminus of human CRY2 was shown to bind the PHR domain and adopt a proteolytically stable structure (20) ; however, no crystal structures of vertebrate cryptochromes thus far have managed to capture the PHR domain bound to its disordered C-terminus, so a complete reckoning of the vertebrate cryptochrome structure still remains to be determined (37, 74) .
Cryptochromes as transcriptional repressors
Circadian rhythms in vertebrates. Circadian rhythms in vertebrates and most insects are driven by a time-delayed transcription-translation feedback loop that shares similarity with the Drosophila clock mechanism through moderate conservation of most of the core clock genes. In vertebrates, the basic helixloop-helix (bHLH) PER-ARNT-SIM (PAS) domain-containing transcription factor complex CLOCK:BMAL1 binds to conserved E-box sequences in the promoters of clock-controlled genes to activate their transcription on a daily basis. Of the approximately 40% of the genome that is rhythmically driven by the circadian clock (88), a small subset of these target genes (Per1, Per2, Cry1, Cry2) make up the core negative component of this feedback loop. Additionally, the nuclear receptors ROR and REV-ERB make up an additional feedback loop that interfaces with the primary loop by controlling the expression of a subset of clock genes, including Bmal1 (89). Large, heteromultimeric PER:CRY complexes slowly enter the nucleus, where they repress CLOCK:BMAL1 activity (90, 91) . Recent data demonstrate the presence of at least two distinct phases of repression: an early repressive PER:CRY complex and a late complex where CRY1 directly inhibits CLOCK:BMAL1-driven transcription independently of PER (92) (93) (94) . Ultimately, the regulated degradation of PER and CRY proteins alleviates repression of CLOCK:BMAL1 activity to allow this cyclical process to begin again. Precise control of protein levels, cellular location and specific complex formation all play an important role in allowing this cycle to occur with~24-h periodicity.
Control of cryptochrome expression. As mentioned above, proper regulation of CRY abundance and subcellular localization is critical for accurate clock timing. At the transcriptional level, specific regulatory mechanisms result in the postponement of Cry1 transcription in relation to Cry2; this phase delay in Cry1 expression is required for 24-h cycling (95) . Post-translational regulation of CRY stability also helps to create necessary delays in abundance that contribute to the 24-h period of the clock. In the nucleus, CRY1 and CRY2 stability is regulated by the Skp1-Cul1-F-box protein FBXL3, which ubiquitinates cryptochromes to induce proteasomal degradation (96) (97) (98) . The related protein FBXL21 was shown to ubiquitinate CRY1 and CRY2 in the cytoplasm (99) . Interestingly, FBXL21 activity was found to antagonize the more efficient activity of the nuclear E3 ligase FBXL3 to finetune CRY protein levels. The small molecule KL001 was shown to bind directly to CRYs and prevent this ubiquitin-dependent degradation, demonstrating for the first time that CRYs could be valuable targets for clock-based therapeutics. KL001 binds in the FAD-binding pocket to compete with FBXL3 binding, resulting in the stabilization of CRY protein levels and lengthening of the circadian period (100, 101) . Clearly, the ability to fine-tune CRY protein levels is important for an accurate and robust cellular clock and also represents a powerful example of a pharmacological strategy to manipulate clock function.
Mechanism of transcriptional repression by cryptochrome. Over the last decade, studies have begun to provide some insight into how cryptochromes inhibit CLOCK:BMAL1-driven transcription. Genetic screens performed concurrently by several groups led to the identification of mutations on both CLOCK and BMAL1 that disrupted the ability of CRY to repress transcription (102,103) ; a similar study by the Green laboratory also identified critical residues on cryptochromes (104) . Further investigations into cryptochrome function demonstrated distinct functions of CRY1 and CRY2 that exist at the biochemical level, showing that only CRY1 is capable of generating cell-autonomous circadian rhythms in fibroblasts and in tissues outside the SCN, while CRY2 cannot (85, 105) . The molecular basis by which a few modest changes in amino acid identity between mammalian CRY1 and CRY2 confer the ability to cycle is not currently understood.
In the late phase of repression, cryptochromes interact directly with CLOCK:BMAL1 on DNA. Aziz Sancar's group first showed this with purified clock proteins, demonstrating their ability to interact both on and off E-box elements in DNA in vitro (94) . A genetic screen in mammalian cells identified that mutations in the PAS-B domain of CLOCK and C-terminal transactivation domain of BMAL1 are important for CRY repression (102) . Subsequent biophysical studies showed that transcriptional repression by CRY1 occurs through competition with transcriptional coactivators for binding the unstructured C-terminal transactivation domain of BMAL1; notably, mutations that altered the balance of repressor and activator binding on BMAL1 were critical for establishing proper period length (106) . In this way, cryptochromes achieve repression of CLOCK:BMAL1 by sequestering the transactivation domain that is needed for activity (103) . Cryptochromes utilize multivalent interactions with both CLOCK and BMAL1 to make stable complexes that allow them to repress activity efficiently when expressed to near-stoichiometric levels with the transcription factor (107) . Notably, introducing only a few point mutations on CLOCK PAS-B as well as the BMAL1 transactivation domain eliminated the ability of CRY1 to repress CLOCK:BMAL1 activity (106) .
Transcriptional regulation by CRYs. While our understanding of circadian regulation of transcription has steadily grown over the last 15 years, until recently, it has not been clear whether the activity of circadian transcriptional regulators was strictly limited to regulation of CLOCK:BMAL1 or whether their influence reaches beyond this complex. Koike et al. (92) addressed this with a large-scale chromatin immunoprecipitation sequencing (ChIP-seq) study that examined patterns of recruitment for the six core clock proteins genomewide in mouse liver over the course of an entire day. This study cataloged daily patterns in recognition and circadian transcriptional control, not only for the core clock proteins, but also for Pol II and other epigenetic markers, to clearly demonstrate genomewide control of the transcriptional landscape by the clock. In addition to providing valuable information about the phase distribution of DNA binding by circadian regulators, this study also identified a large number of sites that are uniquely bound by each of the clock proteins analyzed. For example, CRY1 was found at over 16 000 sites throughout the genome-nearly one-third of which were unique to CRY1 (among all the clock proteins), and CRY2 was found at over 10 000 sites (one-fifth of which were unique to CRY2) (92) . These data strongly suggest that cryptochromes also work outside the core clock transcription-translation loop to regulate transcription throughout the genome. It will be exciting to see how cryptochromes provide temporal regulation to pathways traditionally considered outside the purview of clock-mediated transcription.
New roles for cryptochromes
Communication of temporal information by cryptochromes. While it is well established that cryptochromes are essential for circadian timekeeping, the involvement of CRYs in numerous additional signaling pathways is just beginning to be elucidated (55, 108) . As core clock genes, the expression of cryptochromes follows a rhythmic, circadian pattern of accumulation in nearly every tissue. This universal and time-dependent accumulation of CRY has the potential to impart circadian control on the regulation of downstream pathways throughout the body. In this way, CRY proteins act as a type of time-telling second messenger between the core clock and other cellular processes in which they participate. Many of the signaling pathways that CRYs are known to regulate aside from CLOCK:BMAL1 play key roles in the maintenance of cellular homeostasis such as metabolism, inflammation and DNA damage (109) (110) (111) (112) . These pathways help to maintain cellular and genomic integrity by sensing the current status of the cell (i.e. metabolic, genotoxic stress) and responding to maintain homeostasis (Fig. 3) . In some interesting cases, the stability of CRY proteins is conversely regulated by metabolic and DNA damage signals, helping to form feedback loops that mediate crosstalk between systems (110, 113) . Eliminating cryptochrome-mediated crosstalk through knockdown or genetic ablation of CRYs has been shown in some cases to have deleterious effects (114) . However, the mechanisms by which cryptochromes directly regulate pathways outside of the clock are often not fully understood, especially in cancer (115) . Here, we discuss a few known regulatory roles of cryptochromes outside of the regulation of CLOCK:BMAL1 activity.
Cryptochromes in metabolism.
Epidemiological studies of shift workers show that disruption of circadian rhythms is correlated with increased incidence of metabolic disturbances (116) . In rodents, disruption of the molecular circadian clock led to increased insulin resistance and obesity, emphasizing the intricate link between the circadian clock and metabolism (117) . Increasing evidence shows that cryptochromes play a direct role in glucose homeostasis through mechanisms that are often independent of CLOCK:BMAL1-regulated transcription. Both CRY1 and CRY2 interact with the glucocorticoid receptor (GR) to repress glucocorticoid-stimulated changes in transcription (Fig. 3) (110) . The importance of glucocorticoid signaling to synchronize circadian clocks in peripheral tissues has long been recognized, and recent studies have revealed that CRYs rhythmically antagonize this pathway (118) . Interestingly, CRYs modulate only a subset of GR transcriptional targets; the basis of this selectivity is not yet understood. One of the genes negatively regulated by the GR-CRY1 interaction is the rate-limiting gluconeogenic enzyme, phosphoenolpyruvate carboxykinase 1 (Pck1). By directly controlling the expression of this essential regulatory enzyme, CRYs globally regulate metabolism in response to circulating factors Figure 3 . Roles of CRY outside of CLOCK:BMAL1 regulation. In mammals, CRYs negatively regulate CLOCK:BMAL1 activity to generate a~24-h clock that regulates~40% of the genome (88) . CRY is also reported to regulate GPCR signaling and downstream metabolism through interaction with the G sa subunit to block glucagon-stimulated increases in intracellular cAMP (top left). CRY negatively regulates the glucocorticoid receptor to maintain glucose homeostasis, partly through regulation of Pck1 expression (top right). Interaction of CRY with components of the ATR-mediated DNA damage checkpoint control phase shifting of the clock in response to DNA damage (bottom left). While ablation of the SCN increases tumor formation in mouse models, deletion of cryptochromes extends lifespan after ionizing radiation in a p53 null background (bottom right).
and presumably function to limit glucocorticoid-induced hyperglycemia. Other studies have also identified that cryptochromes interact with the heterotrimeric G protein subunit G sa to modulate the cAMP pathway and CREB activity downstream of G protein-coupled receptors during fasting (Fig. 3) (114) . Consistent with these collective findings, glucose homeostasis is severely disrupted in Cry-deficient mice, further highlighting the importance of cryptochromes in metabolic disease.
DNA damage response. As mentioned previously in this review, CRYs share evolutionary conservation and structural similarity to the DNA damage repair enzyme photolyase. By definition, cryptochromes do not directly repair DNA lesions like photolyase, but they do interface with pathways that modulate the cellular responses to DNA damage (119, 120) . In mammals, CRY1 modulates the ATR-mediated DNA damage checkpoint by interacting with the cell cycle protein TIMELESS (TIM) (121) . There is a substantial degree of sequence homology between mammalian TIM and its counterpart in Drosophila; however, they appear to have evolved different functions in these parallel, yet distinct, mechanisms of timekeeping. Drosophila contains two Tim paralogs, Tim1 (Timeless) and Tim2 (Timeout). While Drosophila TIMELESS is a core clock component that works with PER and CRY to control clock timing in flies (122), TIMEOUT acts outside of the central clock to regulate light entrainment of the adult circadian clock and is essential for DNA metabolism and chromosome integrity (123) . Mammalian TIMELESS is more similar to Drosophila TIMEOUT. Consistent with this, ablation of TIM in mammals resulted in embryonic lethality, and thus, it has been difficult to study behavioral rhythmicity and classify it as an essential clock gene (124) . To date, mammalian TIM is not considered a central clock component. Instead, TIM mediates DNA damage signaling in the ATR-Chk1 pathway to control cell cycle checkpoints (125) (126) (127) . In mammals, cryptochromes maintain their ability to interact with TIM, where it competes with ATRChk1 for a binding site on the N-terminus of TIM (109, 128) . Knockdown of TIM attenuates the canonical phase advance of the circadian system upon DNA damage insults. Mechanistic studies show that TIM interacts with the CC helix (a22) of CRY1 (109) . This helical region of CRY1 is a hotspot for regulation by other proteins, including PER2, FBXL3 and BMAL1 (74, 106, 129, 130) . Indeed, Tamanini and colleagues found that co-expression of PER2 inhibits the formation of a TIM:CRY1 complex, presumably through competition at the CC helix (109). This competitive mechanism for interactions with CRY1 between TIM and other clock proteins that regulate CRY1 stability could represent one manner in which circadian phase is altered in response to genotoxic stress.
Cryptochromes in cancer. Both epidemiological and animal studies show that disruption of circadian rhythms through environmental stimuli (light at night or shift work) or genetic means can lead to an increased incidence of cancer; however, this is confounded by genetic deletion of various clock components and the subsequent array of cancer phenotypes (131, 132) . Circadian disruption appears to play a role in the deregulation of cellular homeostasis and cell cycle control, but the mechanisms by which this occurs are still being identified (133) . Considering that cryptochromes are necessary for circadian timing and regulate vital metabolic processes as well as the UV-induced DNA damage response, deletion of cryptochromes was expected to increase the risk of developing cancer. Furthermore, Cry1 À/À ;Cry2 À/À mice show elevated Wee1 levels in the liver and impaired regeneration, linking cryptochromes and the clock to cell cycle control (134) . Surprisingly, in vivo studies on Cry1 À/À ;Cry2 À/À mice performed by Sancar and colleagues found that these knockout mice do not show an increase in cancer rate compared to wildtype mice, even after exposure to ionizing radiation (135) . Further pursuit of these confounding results found that CRY proteins are actually protective using a p53-mutant background that is more prone to cancer. Deletion of cryptochromes extends the median lifespan of p53 À/À ;Cry1 À/À ;Cry2 À/À mice by 1.5-fold compared to p53 À/À mice (136) . Mechanistic studies in these triple-knockout fibroblasts demonstrated that they were more susceptible than p53 -/--knockout cells to UV-induced apoptosis, implicating cryptochromes in the transmission of p53-independent apoptotic signals in response to DNA damage (136) . Furthermore, downregulation of CRYs was found to modulate levels of inflammatory cytokines and the NF-jb-stimulated transcriptional response that sensitizes cells to apoptosis, linking CRYs to the inflammatory response (111) . These studies revealed that reprogrammed regulatory networks involving CRYs in cancer provide potential for tailored chrono-and chemotherapeutic approaches in p53 null tumors. While deletion of both cryptochromes is required to render mice arrhythmic due to intercellular coupling of the SCN, differences in their clock phenotypes have long been suggested that Cry1 and Cry2 likely have different functions. This was demonstrated in recent study that CRY1 and CRY2 have divergent functions in response to DNA damage (113). Lamia and coworkers showed that CRY1 was stabilized by the ubiquitin-specific protease HAUSP following DNA damage insults, while CRY2 was simultaneously destabilized through preferential interaction with its ubiquitin ligase, FBXL3. Accordingly, Cry1
-/-cells exhibited an increased response to genotoxic stress, while Cry2
-/-cells exhibited a decreased response. These opposing phenotypes suggest that future mechanistic studies are needed to examine independent roles that CRY1 and CRY2 may play, especially as they relate to cancer. Understanding the diverse mechanisms by which cryptochromes work, both inside and outside of the circadian clock, will strengthen our understanding of connection between circadian disruption and disease.
SUMMARY AND PERSPECTIVES
The very name of cryptochromes appropriately hints at our cryptic understanding of their many biological functions (137) . Since their discovery over 20 years ago in plants, a large part of our understanding of cryptochrome function has been drawn from our knowledge of photolyase structure and function (4) . However, it is clear that cryptochromes are a family of functionally diverse proteins in their own right. Some cryptochromes act as photopigments to control circadian photoentrainment and possibly even magnetoreception, while others have apparently lost the ability to sense light and have been co-opted as transcriptional regulators and participants in intracellular signaling cascades that control circadian timing, metabolism and cellular responses to DNA damage. As more insight is brought to light about cryptochrome structure and function, we hope to fully realize their far-reaching influence over many aspects of animal behavior and physiology.
